Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Global Compliance Applications Corp. (CSE: APP) (OTCQB: FUAPF) Is ‘One to Watch’

Global Compliance Applications Corp. (CSE: APP) (OTCQB: FUAPF) is committed to improving the lives of medical cannabis patients, particularly veterans, through a blockchain-powered technology model. The Efixii Uplift platform provides an end-to-end data chain ensuring transparency and efficacy in cannabis products from cultivation to consumption. This Layer -2 Ethereum blockchain platform strengthens the relationship between […]

Annovis Bio Inc. (NYSE: ANVS) Receives FDA Clearance to Initiate Pivotal Phase 3 Alzheimer’s Studies, Paving the Way for NDA Filings

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company focused on developing transformative therapies for neurodegenerative disorders, including Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), recently announced a significant milestone in its drug development process. On October 10, 2024, the company held an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (“FDA”), […]

10th Annual Edition Blockchain Africa Conference 2024 Invites Global Leaders

Bitcoin Events will host the 10th Annual Edition of the Blockchain Africa Conference 2024 on November 20, 2024, at the CSIR International Convention Centre, Tshwane, South Africa. The Blockchain Africa Conference completes 10 years this year, covering 9500+ attendees with 350+ speakers spanning 160 countries. With its experience, knowledge and networking connections, Blockchain Africa Conference […]

Join Kevin O’Leary and Top Investors at NobleCon20

Get ready to discover incredible opportunities at the 20th Emerging Growth Equity Conference hosted by Noble Capital Markets on December 3rd and 4th at Florida Atlantic University. Join Kevin O’Leary, known as “Mr. Wonderful,” along with fellow Shark investors Daymond John and Robert Herjavec, as they meet with entrepreneurs and explore the next big investment […]

Sustain SoCal 15th Annual Energy Event to Address Forward-Looking Decarbonization Solutions

Industries, public and private investment firms, government agencies, banks, innovators, industry leaders, and non-profit organizations, are invited to the Sustain SoCal 15th Annual Energy Event on October 17, 2024, in Irvine, CA. The event agenda comprises discussions, speaker sessions, roundtables, and one-on-one meetings among the company executives and investors. Startups in the sustainability and cleantech […]

BioPharma Formulation & Delivery Nexus in London Encourages Pharmaceutical and Biotech Collaboration

Pharma and biotech executives and professionals, service providers and allied agencies are invited to attend the BioPharma Formulation & Delivery Nexus on November 14-25, 2024, in London, UK.  Scientists, C-level executives, directors, and vice presidents from prestigious organizations in Europe and North America will attend the event. Industry leaders can harness the reach of the […]

World Class Experts to Drive Solutions for Medical Science Liaison Challenges at DGE Philadelphia Conference

MSLs serve as vital links between drug developers, healthcare managers, and opinion influencers in the biopharma industry. The quality and effectiveness of MSL work output can be more difficult to measure than those of other teams, but company management will nonetheless seek metrics to determine how MSLs are helping to advance commercial sales goals. Medical […]

 

From Our Blog

Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-Powered Platform Delivers Promising and Durable Results in Lung Cancer Trial

June 26, 2025

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development, recently reported an encouraging clinical outcome in its Phase 2 HARMONIC(TM) trial, where a patient with advanced non-small cell lung cancer (“NSCLC”) achieved a complete response using LP-300, a compound optimized through Lantern’s AI-powered platform, RADR(R) […]

Rotate your device 90° to view site.